American Cancer Society Recommends Prostate Screening
Tap title to read story
The American Cancer Society has issued a new guideline urging men to undergo prostate cancer screening. The update recommends screening every two years for men at average risk beginning at age fifty, and annual screening for Black men and those with a strong family history starting at forty‑five. The change follows evidence that regular PSA testing reduces mortality. Previously, the 2010 guideline emphasized informed decision‑making without a direct recommendation. The 2023 guideline, published in CA: A Cancer Journal for Clinicians, clarifies that men over seventy should again decide individually. Experts say the clearer guidance will increase screening uptake and potentially save lives.
More context
Timeline
- On May 8 2018 USPSTF recommends discussion for men fifty‑to-sixty‑nine.
- On November 22 2023 American Cancer Society publishes new screening recommendation.
Why it matters
Immediate US impact: Increased screening rates may reduce mortality. Possible long-term US impact: Longer term could lower prostate cancer deaths. Most affected groups: Men, especially Black men and those with family history. Reader priority: Understand new screening schedule and eligibility.
Coverage notes
Center: Coverage from CNN, The Guardian, UW Medicine | Newsroom frames this as a developing news story: American Cancer Society Recommends Prostate Screening. Reporting emphasizes verified facts, named sources, and near-term impact for readers. Left: Left-leaning desks covering the same development typically emphasize public impact, institutional accountability, and who is most affected. Right: Right-leaning desks covering the same development typically emphasize practical outcomes, market or security stakes, and institutional response.
Primary report
CNN — American Cancer Society Recommends Prostate Screening
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
